[{"ID":"8479_12_NCT03009331","TOPIC_YEAR":2022,"RESPONSE":"Our patient is ineligible for the clinical trial as he has a diagnosis of pleurisy, which falls under the exclusion criteria of \"Diagnose of obstructive or restrictive lung disease\" and therefore cannot participate.","PROBA":0.6822483852},{"ID":"5254_12_NCT00629902","TOPIC_YEAR":2021,"RESPONSE":": Inclusion Criteria:\n\n- Patients > 18 years with a clinical condition of mitral valve prosthesis: Eligible\n- prosthetic mitral valve replacement operation < 6 months: Not Eligible\n- Left ventricular ejection fraction < 50%: Not Relevant for Clinical Trial\n- Chronic obstructive pulmonary disease: Not Relevant for Clinical Trial\n- Concomitant hypertrophic cardiomyopathy, atrial septal defect: Not Relevant for Clinical Trial\nExclusion Criteria:\n\n- Evidence of prosthesis valve dysfunction: Not Relevant for Clinical Trial\n- Concomitant aortic valve prosthesis and tricuspid valve prosthesis: Not Relevant for Clinical Trial\n- Prosthetic mit","PROBA":0.9517484975},{"ID":"25379_36_NCT02894151","TOPIC_YEAR":2022,"RESPONSE":"\nInclusion Criteria:\n\nage 18-45 years: Eligible\nPelvic pain VAS>50: Eligible\nPrevious sexual intercourse: Eligible\nGender: Female: Eligible\nMinimum age: 18 Years: Eligible\nMaximum age: 45 Years: Eligible\nHealthy volunteers: Accepts Healthy Volunteers: Not Relevant for Clinical Trial\n\nExclusion Criteria:\n\nother genital tract disease causing pelvic pain: Not Relevant for Clinical Trial\nPrevious hormonal treatment 3 month: Not Relevant for Clinical Trial\nHistory of DMPA treatment failure: Not Relevant for Clinical Trial\nWHO eligibility criteria 2009 categorized in 3-4 for DMPA and LNG-IUS user","PROBA":0.9669848756},{"ID":"10394_15_NCT04133883","TOPIC_YEAR":2022,"RESPONSE":"\nBased on the provided patient note and the inclusion criteria for the clinical trial, the patient is not eligible for the clinical trial since the patient has been diagnosed with DMD, which is not a type of haemophilia. Therefore, the patient does not meet the inclusion criteria for the clinical trial.\n\nSo, the patient is \"not eligible\" for the clinical trial.","PROBA":0.873926842},{"ID":"10330_15_NCT03574922","TOPIC_YEAR":2022,"RESPONSE":" Not eligible; the patient does not meet the inclusion criteria of being a hemophilia patient.","PROBA":0.7106967795},{"ID":"27493_40_NCT00405613","TOPIC_YEAR":2022,"RESPONSE":"(eligible, not eligible, not relevant for clinical trial)","PROBA":0.9108658085},{"ID":"8185_12_NCT00870246","TOPIC_YEAR":2022,"RESPONSE":"OYes, the patient is eligible for the clinical trial. The patient has chronic obstructive pulmonary disease (COPD) which is one of the inclusion criteria. The patient also is over the age of 50 and does not meet any of the exclusion criteria. Therefore, the patient is eligible to participate in the clinical trial.","PROBA":0.8222579949},{"ID":"11461_17_NCT00760240","TOPIC_YEAR":2022,"RESPONSE":"$eligible$","PROBA":0.6473544172},{"ID":"8025_17_NCT03288922","TOPIC_YEAR":2021,"RESPONSE":"?eligible?","PROBA":0.5158824361},{"ID":"25227_53_NCT02585739","TOPIC_YEAR":2021,"RESPONSE":"?eligible","PROBA":0.5061682426},{"ID":"18898_40_NCT00453128","TOPIC_YEAR":2021,"RESPONSE":"\nEligible","PROBA":0.6049123317},{"ID":"27649_40_NCT01541241","TOPIC_YEAR":2022,"RESPONSE":"OYes, the patient is eligible for the clinical trial. Based on the inclusion criteria provided, the patient meets all of the criteria listed:\n\n1. Regularly menstruating women before CIUD insertion: Eligible\n2. Age between 18 and 35 years: Eligible\n3. Hormonal treatment has not been taken at least two months before the study: Eligible\n4. Non steroidal anti-inflammatory drugs has not been taken 24 hours before the examination: Eligible\n\nThe patient does not meet any of the exclusion criteria listed either.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9298671153},{"ID":"18812_27_NCT01812395","TOPIC_YEAR":2022,"RESPONSE":"'eligible'","PROBA":0.676869153},{"ID":"8462_12_NCT02892396","TOPIC_YEAR":2022,"RESPONSE":": eligible","PROBA":0.7128439231},{"ID":"25029_53_NCT01026584","TOPIC_YEAR":2021,"RESPONSE":"O: eligible","PROBA":0.6282131498},{"ID":"12671_27_NCT02813057","TOPIC_YEAR":2021,"RESPONSE":"Oops, it looks like the patient is not eligible for the clinical trial, as the patient has a history of inguinal hernia surgery, which is an exclusion criterion for the study. The patient may have had the hernia repaired on the opposite side, which would disqualify the patient from participating in the study. Additionally, the study is focused on the effects of the hernia repair procedure on the lower extremity muscles, and the patient's recent hernia repair history may not be relevant to the study's objectives.\n\nBased on the provided information and the criteria for the clinical trial, the patient is \"not eligible\" for the clinical trial.","PROBA":0.7989317088},{"ID":"33651_71_NCT02228343","TOPIC_YEAR":2021,"RESPONSE":"","PROBA":0.0464498438},{"ID":"30674_65_NCT01887431","TOPIC_YEAR":2021,"RESPONSE":"Oops, my apologies! Based on the information you provided about the patient and the trial, it appears that the patient would be ineligible for the clinical trial. Here's why:\n\nThe patient is a 25-year-old man with type 1 diabetes, which meets the trial's inclusion criterion of lasting >1 year. However, the patient is too young to meet the trial's age requirement of 22 years or older.\n\nAdditionally, the patient does not possess a mobile phone or internet access, which violates the trial's exclusion criterion.\n\nSo, the patient would not be eligible for the clinical trial based on the information provided.","PROBA":0.7651884433},{"ID":"25445_53_NCT04709744","TOPIC_YEAR":2021,"RESPONSE":"\nInclusion Criteria:\n\nSLE patients previously diagnosed: Eligible\nPatients are not suffering from malignancies: Eligible\nPatients have no organ failure nor uncontrolled medical illness: Eligible\nRecent COVID-19 infection: Not Relevant for Clinical Trial\n\nExclusion Criteria:\n\nPregnant, lactating females: Not Relevant for Clinical Trial\nConcurrent malignancies: Not Relevant for Clinical Trial\nPatients with other autoimmune disease: Not Relevant for Clinical Trial\n\nBased on the provided information and the criteria for the clinical trial, the patient would likely not be considered eligible for the clinical trial since she does not have a prior diagnosis of SLE and is not currently experiencing symptoms of COVID-19.\n\nSo, the patient is \"not","PROBA":0.9486981084},{"ID":"10309_15_NCT03372655","TOPIC_YEAR":2022,"RESPONSE":"Others:\nNot eligible\n\nThe patient is not eligible for the clinical trial because they are outside the age range of the trial (being 8 years old instead of 10-18 years old).","PROBA":0.775477332},{"ID":"27486_40_NCT00371683","TOPIC_YEAR":2022,"RESPONSE":"Our patient is ineligible for the clinical trial because she has a history of heavy menstrual cycles, which are a preexisting condition that the investigators are trying to exclude. As her history of heavy menstrual cycles is relevant for the current study, the patient would not be eligible.\n\nTherefore, the patient is \"not eligible\" for the clinical trial.","PROBA":0.6712905092},{"ID":"8152_12_NCT00611182","TOPIC_YEAR":2022,"RESPONSE":"Onotera c: Eligible","PROBA":0.4233409814},{"ID":"21209_30_NCT03058380","TOPIC_YEAR":2022,"RESPONSE":"> eligible","PROBA":0.7152099874},{"ID":"16869_36_NCT00172523","TOPIC_YEAR":2021,"RESPONSE":"Oligomenorrhea: Eligible\nHyperandrogenism: Eligible\nPCO by ultrasound: Eligible\nAge: Eligible\nGender: Eligible\nNo hormone therapy in the past 6 months: Eligible\nNo pregnancy in the past 6 months: Eligible\nNo acute illness found in the past 3 months: Eligible\nNo systemic disease including autoimmune disease, malignancy, hepatic, renal or CVS disease: Eligible\nNo ever received chemotherapy or immunosuppressive agents: Eligible\n\nBased on the provided information and the criteria for the clinical trial, the patient is likely eligible for the clinical trial. Therefore, the patient is \"eligible\" for the clinical trial.","PROBA":0.942078256},{"ID":"18861_27_NCT02367222","TOPIC_YEAR":2022,"RESPONSE":"Oops!\n\nThe patient is not eligible for the clinical trial because she has a current diagnosis of Lyme disease, which is a demyelinating condition and is excluded from the study.\n\nBased on the above information, the patient is \"not eligible\" for the clinical trial.","PROBA":0.8108623579},{"ID":"33904_71_NCT04215380","TOPIC_YEAR":2021,"RESPONSE":"(eligible, not eligible, not relevant for clinical trial)","PROBA":0.9120077576},{"ID":"11902_17_NCT03855670","TOPIC_YEAR":2022,"RESPONSE":"Ocular examination shows loss of the red reflex and blurry vision. Acuity testing shows 50\/100 vision in both eyes with normal visual field testing. His blood pressure is 130\/70 and pulse is 68\/min. the other physical examinations are normal.\n\nHe does not meet the inclusion criteria of having COPD, as the condition he is presenting with is a slowly worsening vision in both eyes, which is not related to COPD. Furthermore, the patient is not a healthy volunteer as he has a medical condition.\n\nTherefore, based on the provided information and the criteria for the clinical trial, the patient would not be considered eligible for the clinical trial and would be \"not eligible\".","PROBA":0.8565635049},{"ID":"25106_53_NCT01596244","TOPIC_YEAR":2021,"RESPONSE":"Oops, it looks like the patient is not eligible for the clinical trial. The patient has general and non-specific bones and joints pain, which does not fit the inclusion criteria of having diabetes or pre-diabetes. Additionally, the patient is not mentally competent as they are not able to make changes to their diet or level of physical activity due to significant medical complications. Therefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"not eligible\" for the clinical trial.","PROBA":0.8713936299},{"ID":"18912_40_NCT00663988","TOPIC_YEAR":2021,"RESPONSE":"O: Not eligible\nThe patient is not eligible for the clinical trial because the patient has a medical condition (Paget's Disease of Bone) that is not related to the condition being studied in the clinical trial (Human Partial Facial Allotransplantation). Additionally, the patient is not within the age range specified in the clinical trial (18-40 years) and has a history of medical conditions that would make them ineligible (hypertension in his mother and DM type 2 in his father). So, the patient is \"not eligible\" for the clinical trial.","PROBA":0.8429231523},{"ID":"11670_17_NCT02033200","TOPIC_YEAR":2022,"RESPONSE":"(eligible, not eligible, not relevant for clinical trial)","PROBA":0.9185785995},{"ID":"8130_12_NCT00430664","TOPIC_YEAR":2022,"RESPONSE":"= eligible","PROBA":0.707493891},{"ID":"30468_65_NCT00519935","TOPIC_YEAR":2021,"RESPONSE":"#eligible #not eligible #not relevant for clinical trial","PROBA":0.8491248278},{"ID":"8031_17_NCT03348059","TOPIC_YEAR":2021,"RESPONSE":"[eligible]","PROBA":0.7043063276},{"ID":"25614_36_NCT04626544","TOPIC_YEAR":2022,"RESPONSE":"O: Not eligible \nE: Eligible \nN: Not relevant for clinical trial","PROBA":0.7709379638},{"ID":"8552_12_NCT03542318","TOPIC_YEAR":2022,"RESPONSE":"O Based on the provided information, the patient is eligible for the clinical trial.\nO The patient does not meet the inclusion criteria for the clinical trial.\nO The patient meets the inclusion criteria for the clinical trial.\n\nB Based on the provided information, the patient does not meet the inclusion criteria for the clinical trial.","PROBA":0.8090789782},{"ID":"5294_12_NCT01305148","TOPIC_YEAR":2021,"RESPONSE":"(eligible, not eligible, not relevant for clinical trial)","PROBA":0.9186893557},{"ID":"11591_17_NCT01586234","TOPIC_YEAR":2022,"RESPONSE":"Ocular examination shows loss of the red reflex and blurry vision: Eligible\nOther medical history is unremarkable: Eligible\nInability to give informed consent: Not Relevant for Clinical Trial\nInability to maintain stable fixation for OCT imaging: Not Relevant for Clinical Trial\nInability to commit to required visits to complete the study: Not Relevant for Clinical Trial\nEyes with concurrent cataract, retinal diseases, glaucoma, or other eye conditions that may limit the visual outcome after surgery: Not Relevant for Clinical Trial\nBased on the provided information and the criteria for the clinical trial, the patient would likely be considered eligible for the clinical trial since she meets the inclusion criteria and does not meet the specified exclusion criteria.\n\nSo, the patient is \"eligible\" for the clinical trial","PROBA":0.9708237944},{"ID":"5325_12_NCT01777815","TOPIC_YEAR":2021,"RESPONSE":"+ eligible: yes\/no\n\nNo, the patient is not eligible for the clinical trial. The patient does not meet the inclusion criteria of the study, specifically the exclusion criterion of \"anterior or bi-leaflet prolapse.\" The patient has a history of severe mitral regurgitation with posterior leaflet prolapse, which makes them ineligible for the study.","PROBA":0.8232328304},{"ID":"12479_27_NCT01241227","TOPIC_YEAR":2021,"RESPONSE":"II: Eligible","PROBA":0.598146363},{"ID":"11808_17_NCT03076697","TOPIC_YEAR":2022,"RESPONSE":"Ocular Examination:\n\nThe patient is eligible for the clinical trial because the patient's slowly worsening vision in both eyes meets the inclusion criteria for the clinical trial, which states that the patient must have eye diseases as a result of diabetes, glaucoma, age-related macular degeneration, retinopathy of prematurity. The patient's age and gender also meet the inclusion criteria.\n\nThe patient is not eligible for the clinical trial because of loss of the red reflex and blurry vision, and acuity testing. These symptoms are not included in the inclusion criteria.\n\nBased on the above information, the patient is eligible for the clinical trial.","PROBA":0.8085575574},{"ID":"8227_12_NCT01230879","TOPIC_YEAR":2022,"RESPONSE":"","PROBA":0.0476029143},{"ID":"7689_17_NCT00149136","TOPIC_YEAR":2021,"RESPONSE":"\nBased on the provided information and the criteria for the clinical trial, the patient would not be eligible for the clinical trial since she has multiple myeloma, which is a different type of cancer from Philadelphia-positive acute lymphocytic leukemia (Ph+ ALL) that is being studied in the clinical trial. The patient's inclusion criteria do not meet the requirements for the clinical trial.\n\nTherefore, the patient is \"not eligible\" for the clinical trial.","PROBA":0.8543261209},{"ID":"25035_36_NCT00013390","TOPIC_YEAR":2022,"RESPONSE":"Oops, looks like I made a mistake in my previous answer. Based on the information provided, the patient is not eligible for the clinical trial. Here's why:\n\nInclusion Criteria:\n\n* Patients with significant tinnitus\n\nThe patient does not have tinnitus, as the symptoms she is experiencing are dizziness and nausea, and occasional ringing in her right ear. Therefore, she does not meet the inclusion criteria for the clinical trial.\n\nExclusion Criteria:\n\n* Patients with a history of significant hearing loss\n\nThe patient does have sensorineural hearing loss in the left ear, which is a history of significant hearing loss. Therefore, she meets the exclusion criteria for the clinical trial.\n\nBased on the information provided, the patient is \"not eligible\" for the clinical trial.","PROBA":0.877995607},{"ID":"17185_36_NCT02726048","TOPIC_YEAR":2021,"RESPONSE":"Obesity is not a specific exclusion criteria for this clinical trial, so the patient would be considered eligible for the clinical trial since she meets the inclusion criteria and does not meet the specified exclusion criteria.","PROBA":0.8001369094},{"ID":"5363_12_NCT02276547","TOPIC_YEAR":2021,"RESPONSE":": eligible","PROBA":0.74788871},{"ID":"27961_40_NCT03729323","TOPIC_YEAR":2022,"RESPONSE":"= eligible","PROBA":0.65582017},{"ID":"10122_15_NCT01611597","TOPIC_YEAR":2022,"RESPONSE":"(eligible \/ not eligible \/ not relevant for clinical trial)","PROBA":0.9009646976},{"ID":"18686_27_NCT00400465","TOPIC_YEAR":2022,"RESPONSE":"O01c: Not Eligible","PROBA":0.444406565},{"ID":"25462_53_NCT04803526","TOPIC_YEAR":2021,"RESPONSE":"Oops! I apologize for the mistake. The patient is not eligible for the clinical trial.\n\nExclusion Criteria:\n\nCurrently married women: Not Relevant for Clinical Trial\nGender:Not Relevant for Clinical Trial\nMinimum age:Not Relevant for Clinical Trial\nMaximum age:Not Relevant for Clinical Trial\nHealthy volunteers:Not Relevant for Clinical Trial\n\nBased on the provided information, the patient does not meet any of the inclusion criteria or none of the exclusion criteria for the clinical trial. Therefore, the patient is \"not eligible\" for the clinical trial.","PROBA":0.8628117212},{"ID":"21203_30_NCT03034733","TOPIC_YEAR":2022,"RESPONSE":")Not eligible\" for the clinical trial, based on the inclusion and exclusion criteria.\n\nHere is the reason why:\n\nInclusion Criteria: primary total knee replacement surgery - The patient does not meet this inclusion criterion because she is complaining of pain in the calf and knee when bending down, which is not related to a total knee replacement surgery.\n\nExclusion Criteria: severe coronary artery disease, heart failure, kidney failure - insulin-dependent DM (diabetes mellitus), poorly controlled type II DM - gastric\/duodenal ulcer - Allergy\/contra-indication for any drug used in the study - corticosteroid use during last 3 months - preoperative use of opioid drugs (excl. codeine, tramadol) - neuropathy\/sensory impairment of","PROBA":0.8798145931}]
